Exane Derivatives’s Virgin Galactic SPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-119
Closed -$23.5K 900
2022
Q1
$23.5K Buy
+119
New +$22.2K 0.01% 649
2021
Q4
Sell
-179
Closed -$90.4K 955
2021
Q3
$90.4K Sell
179
-34
-16% -$20.2K 0.02% 534
2021
Q2
$160K Sell
213
-203
-49% -$115K 0.04% 453
2021
Q1
$255K Buy
416
+341
+455% +$257K 0.07% 261
2020
Q4
$35.6K Sell
75
-75
-50% -$35K 0.01% 482
2020
Q3
$57.7K Buy
+150
New +$56.9K 0.02% 368

Other funds holding SPCE

Exane Derivatives's SPCE Position: Q2 2022 in Review

Exane Derivatives sold out of Virgin Galactic (SPCE) in Q2 2022, closing a stake of 119 shares — an estimated $23.5K sold.

Exane Derivatives first reported a position in SPCE in Q3 2020 and held it in 6 quarters. The position peaked at $255K in Q1 2021. 267 funds tracked by Wall St. Rank hold SPCE as of Q2 2022.

  • Exane Derivatives reported no remaining Virgin Galactic position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 119 Virgin Galactic shares in Q2 2022, an estimated $23.5K.
  • Exane Derivatives first reported a position in Virgin Galactic in Q3 2020 and held it in 6 quarters.
  • Exane Derivatives's Virgin Galactic position peaked at $255K in Q1 2021.
  • 267 funds tracked by Wall St. Rank held Virgin Galactic as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.